Name | Adenosine 5'-triphosphate disodium salt | ||
---|---|---|---|
CAS Number | 987-65-5 | Molecular Weight | 551.145 |
Density | 2.63g/cm3 | Boiling Point | 951.4ºC at 760mmHg |
Molecular Formula | C10H14N5Na2O13P3 | Melting Point | 188-190ºC |
MSDS | N/A | Flash Point | N/A |
Name | Adenosine 5'-triphosphate disodium salt ATP |
aliases | 5’-ATP, 2Na; ATP-Na2; 5’-Adenosinetriphosphoric acid disodium salt |
CAS No. | 987-65-5; 51963-61-2 |
EINECS No. | 213-579-1 |
Molecular formula | C10H14N5Na2O13P3 |
Molecular weight | 551.16 |
Structural formula | |
Physical properties | This product is a white to off-white powder or crystalline powder;hygroscopicity;freely soluble in water, insoluble in ethanol, chloroform and ether. |
Purity(HPLC) | ≥99% |
Usage | 1.Clinically used for tissue damage, cell enzyme activity decline caused by various diseases.Such as heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary atherosclerosis, progressive muscle atrophy, cerebral hemorrhage sequelae, acute or chronic hepatitis, cirrhosis and hearing impairment, etc. 2.Adenosine triphosphate disodium is coenzyme drugs, used in progressive muscular dystrophy, cerebral apoplexy sequelae, cardiac insufficiency, myocardial disease, hepatitis treatment, etc.Clinically used for tissue damage, cell enzyme activity decline caused by various diseases.Such as heart failure, myocarditis, myocardial infarction, cerebral arteriosclerosis, coronary atherosclerosis, progressive muscle atrophy, cerebral hemorrhage sequelae, acute or chronic hepatitis, cirrhosis and hearing impairment, etc. 3.Adenosine triphosphate disodium is coenzyme drugs, used in progressive muscular dystrophy, cerebral apoplexy sequelae, cardiac insufficiency, myocardial disease, hepatitis treatment, etc. |
Packing size | 20kg/barrel(GMP), 25kg/barrel |
Storage | Keep dry and away from light and stored in ventilated cool library |
Your email address will not be published. Required fields are marked *